Weight-Loss Drugs Reshaped Obesity Care, But Surgery Refuses to Fade
As powerful new weight-loss drugs transform obesity treatment, leading surgeons argue that metabolic bariatric surgery remains an essential, durable component ...
As powerful new weight-loss drugs transform obesity treatment, leading surgeons argue that metabolic bariatric surgery remains an essential, durable component ...
Researchers in China have developed MKMed, a cross-modal AI framework that aligns five types of drug knowledge to overcome the ...
A letter in European Geriatric Medicine argues that disputes over the STOPP/START criteria expose the need for transparent evidence-grading standards ...
A new review argues that Brixadi, an extended-release injectable buprenorphine approved for opioid use disorder, warrants clinical investigation as a ...
A nationwide Finnish register study of 282,307 adults examines how sociodemographic and socioeconomic factors shape who uses anti-obesity medications.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine